Compare BNTX & ON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | ON |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 22.1B |
| IPO Year | 2019 | 2000 |
| Metric | BNTX | ON |
|---|---|---|
| Price | $110.12 | $68.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 25 |
| Target Price | ★ $140.31 | $64.46 |
| AVG Volume (30 Days) | 653.0K | ★ 9.1M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $5,878,300,000.00 |
| Revenue This Year | $2.58 | $8.05 |
| Revenue Next Year | N/A | $10.16 |
| P/E Ratio | ★ N/A | $238.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.12 | $31.04 |
| 52 Week High | $124.00 | $73.76 |
| Indicator | BNTX | ON |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 59.40 |
| Support Level | $106.21 | $67.02 |
| Resistance Level | $112.68 | $73.76 |
| Average True Range (ATR) | 2.96 | 2.90 |
| MACD | -0.49 | 0.16 |
| Stochastic Oscillator | 60.80 | 68.12 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.